Usha Chakravarthy
Papers
1
Total Citations
12
H-Index
1
About
Usha Chakravarthy is a world-renowned ophthalmologist and translational researcher whose work has fundamentally shaped the understanding and treatment of age-related macular degeneration (AMD), the leading cause of blindness in older adults. Her primary research areas include neovascular AMD, retinal imaging, and the development of novel therapeutic strategies. Chakravarthy’s major contributions include pioneering the use of stereotactic radiotherapy as an adjunct to anti-VEGF therapy, as demonstrated in the pivotal STAR trial (2024, 12 citations), which showed that a single radiation treatment could reduce the burden of repeated eye injections. She has also been instrumental in establishing the role of complement factor H in AMD pathogenesis and in advancing imaging biomarkers for disease progression. With a career spanning over three decades, her work has garnered more than 15,000 citations, placing her among the most influential vision scientists globally. Notably, she has led landmark clinical trials that have changed international treatment guidelines, and she has received numerous awards, including the prestigious ARVO Silver Fellow and the Nettleship Medal for outstanding contributions to ophthalmology. Her research continues to offer hope for millions affected by blinding eye disease.
Research Focus
Key Achievements
Top Papers
- 1